This research report includes a detailed segmentation of the global viral conjunctivitis drugs market by route of administration (topical, oral, and intravitreal). It outlines the market shares of key regions such as the Americas, APAC, and EMEA. The key vendors analyzed in this report are Akorn, Alcon, Allergan, and Bausch & Lomb. Technavio’s market…
Dermatophytic onychomycosis: Key market research findings Increased focus on combination therapies Growing investments in research activities Technavio has released a new market research report on the global dermatophytic onychomycosis market, which is expected to grow at a CAGR of 7% by 2020. Walking barefoot in damp public places, immunosuppressive conditions such as HIV, excessive…
This market research report includes a detailed segmentation of the global bacterial conjunctivitis drugs market by drug class (fluoroquinolones, aminoglycosides, macrolides, and others). It also outlines the market shares for key regions such as the Americas, APAC, and EMEA. The top vendors analyzed in this report are Akorn, Alcon, Allergan, and Bausch & Lomb….
This market study from Technavio segments the global conjunctivitis market by disease type (bacterial conjunctivitis, viral conjunctivitis, and allergic conjunctivitis) and by geography (APAC, EMEA, and the Americas). The report also provides an analysis of the key trends and vendors in this market, including Akorn, Alcon, Allergan, and Bausch & Lomb. Technavio’s market research…
Antibacterial drugs: key market research findings Increase in awareness and patient assistance programs Rise in the prevalence of beta-lactams Technavio has added a new market research report on the global antibacterial drugs market, to its drugs portfolio. The global antibacterial drugs market is expected to grow at a modest CAGR of around 1% because…
This market research report presents a detailed analysis of the key drivers, challenges, and upcoming trends that influence the prospects for growth in this market. Leading vendors analyzed in this market research are Amicus Therapeutics, BioMarin Pharmaceutical, and Genzyme. Technavio has released its new market research report, Pompe disease market in the US, which…
HUV drugs: Key market research findings Increased funding for upscaling the HIV drugs consumption Nucleoside reverse transcriptase inhibitors segment to exceed US $5,500 million by 2019 Technavio has added a new market research report on the global HIV drugs market, which is expected to grow at a CAGR of more than 4% between 2015…
This market research report segments the global hospital infection therapeutics market by drug class (antibacterial, antiviral, and antifungal), by type of infections (urinary tract infections, respiratory tract infections, bloodstream infections, surgical site infections, and gastrointestinal infections), and by geography (APAC, EMEA, and the Americas). Leading vendors analyzed in this market study are Allergan, Bayer,…
The key vendors in the global preventive asthma drugs market 2015-2019 are AstraZeneca, F. Hoffmann-La Roche, GlaxoSmithKline, Merck, and Novartis. London, 29 September 2015: Technavio, an independent tech-focused global research firm, has announced the publication of its market research report on the global preventive asthma drugs market 2015-2019. Biologics are increasingly becoming the…
